The Challenge
Clinical development leaders at a global pharmaceutical company faced mounting pressure to accelerate trials, but fragmented processes, multiple vendors, and disconnected systems made execution difficult.
Critical milestones depended on external handoffs that slowed delivery, introduced rework, and limited visibility into progress. Teams lacked a consistent operating model for governing and executing key trial activities.
Improving individual processes wasn't enough. The organization needed greater operational control across the clinical trial lifecycle.
The Opportunity
The organization chose to bring critical clinical operations capabilities in-house to reduce dependency on vendors and regain control of execution.
Point B translated that strategic decision into an operating model that standardized execution across studies, improved governance, and delivered faster access to decision-grade information.
Four priorities guided the transformation:
- Regain control of critical milestones
- Standardize execution across the trial lifecycle
- Automate routine work while reducing risk
Establish governance for continuous improvement
TextContentTiles
JSS component is missing React implementation. See the developer console for more information.
Outcomes
The transformation increased operational control while improving speed, consistency, and scalability across active global studies.
Operational Impact
- Database lock reduced from multi-day vendor cycles to same-day execution
- 250+ processes simplified into 60 standardized workflows
- 60+ stakeholders aligned under one operating model
Business Impact
- Faster access to top-line study results, enabling more timely portfolio decisions.
- Improved inspection readiness and reduced execution risk
- Reduced dependency on external vendors
- Greater confidence in planning and execution
- Scalable operating model that can be replicated across future studies
Key Takeaway
At its core, this wasn't a process improvement initiative. It was a strategic shift that gave the organization control over how clinical trials are executed.
By combining governance, standardized execution, and automation, Point B helped create a clinical operations model that accelerates delivery while building capability for the future. Operational excellence became a competitive advantage, not just an efficiency initiative.
RELATED INDUSTRIES
